Hortobagyi GN - Search Results

1

Genomic grade index is associated with response to chemotherapy in patients with breast cancer.

Liedtke C, Hatzis C, Symmans WF, Desmedt C, Haibe-Kains B, Valero V, Kuerer H, Hortobagyi GN, Piccart-Gebhart M, Sotiriou C, Pusztai L. Liedtke C, et al. Among authors: hortobagyi gn. J Clin Oncol. 2009 Jul 1;27(19):3185-91. doi: 10.1200/JCO.2008.18.5934. Epub 2009 Apr 13. J Clin Oncol. 2009. PMID: 19364972 Free PMC article.

2

Adjuvant therapy with escalating doses of doxorubicin and cyclophosphamide with or without leukocyte alpha-interferon for stage II or III breast cancer.

Buzdar AU, Hortobagyi GN, Kau SW, Smith TL, Fraschini G, Holmes FA, Gutterman JU, Hug VM, Singletary SE, Ames FC, et al. Buzdar AU, et al. Among authors: hortobagyi gn. J Clin Oncol. 1992 Oct;10(10):1540-6. doi: 10.1200/JCO.1992.10.10.1540. J Clin Oncol. 1992. PMID: 1403033 Clinical Trial.

3

Bone metastasis in breast cancer.

Theriault RL, Hortobagyi GN. Theriault RL, et al. Among authors: hortobagyi gn. Anticancer Drugs. 1992 Oct;3(5):455-62. doi: 10.1097/00001813-199210000-00002. Anticancer Drugs. 1992. PMID: 1450438 Review.

4

Activity of ifosfamide in breast cancer.

Hortobagyi GN. Hortobagyi GN. Semin Oncol. 1992 Dec;19(6 Suppl 12):36-41. Semin Oncol. 1992. PMID: 1485173 Review.

5

Feasibility of breast-conservation surgery after induction chemotherapy for locally advanced breast carcinoma.

Singletary SE, McNeese MD, Hortobagyi GN. Singletary SE, et al. Among authors: hortobagyi gn. Cancer. 1992 Jun 1;69(11):2849-52. doi: 10.1002/1097-0142(19920601)69:11<2849::aid-cncr2820691134>3.0.co;2-p. Cancer. 1992. PMID: 1571916

6

Treatment of locally advanced breast cancer.

Booser DJ, Hortobagyi GN. Booser DJ, et al. Among authors: hortobagyi gn. Semin Oncol. 1992 Jun;19(3):278-85. Semin Oncol. 1992. PMID: 1609294 Review.

7

Lack of correlation between histologic findings and response to chemotherapy in metastatic breast cancer.

Ziegler LD, Connelly JH, Frye D, Smith TL, Hortobagyi GN. Ziegler LD, et al. Among authors: hortobagyi gn. Cancer. 1991 Aug 1;68(3):628-33. doi: 10.1002/1097-0142(19910801)68:3<628::aid-cncr2820680331>3.0.co;2-3. Cancer. 1991. PMID: 1648436

8

Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapy.

Buzdar AU, Kau SW, Hortobagyi GN, Ames FC, Holmes FA, Fraschini G, Hug V, Theriault RL, McNeese MD, Singletary SE. Buzdar AU, et al. Among authors: hortobagyi gn. Cancer. 1992 Jan 15;69(2):448-52. doi: 10.1002/1097-0142(19920115)69:2<448::aid-cncr2820690229>3.0.co;2-k. Cancer. 1992. PMID: 1728373

9

Phase II evaluation of interferon added to tamoxifen in the treatment of metastatic breast cancer.

Macheledt JE, Buzdar AU, Hortobagyi GN, Frye DK, Gutterman JU, Holmes FA. Macheledt JE, et al. Among authors: hortobagyi gn. Breast Cancer Res Treat. 1991 Aug;18(3):165-70. doi: 10.1007/BF01990032. Breast Cancer Res Treat. 1991. PMID: 1756259 Clinical Trial.

10

Evaluation of three oral dosages of ondansetron in the prevention of nausea and emesis associated with cyclophosphamide-doxorubicin chemotherapy.

Fraschini G, Ciociola A, Esparza L, Templeton D, Holmes FA, Walters RS, Hortobagyi GN. Fraschini G, et al. Among authors: hortobagyi gn. J Clin Oncol. 1991 Jul;9(7):1268-74. doi: 10.1200/JCO.1991.9.7.1268. J Clin Oncol. 1991. PMID: 1828499 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,106 results

Search Page

Filters